Ranjit Manchanda
Ranjit Manchanda
Professor of Gynaecological Oncology and Consultant Gynaecological Oncologist
Verified email at
Cited by
Cited by
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
I Jacobs, A Gentry-Maharaj, M Burnell, R Manchanda, N Singh, A Sharma, ...
The lancet oncology 12 (1), 38-48, 2011
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ...
Genetics in Medicine 21 (10), 2390-2400, 2019
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial
R Manchanda, K Loggenberg, S Sanderson, M Burnell, J Wardle, ...
Journal of the National Cancer Institute 107 (1), dju379, 2015
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing
R Manchanda, R Legood, M Burnell, A McGuire, M Raikou, K Loggenberg, ...
Journal of the National Cancer Institute 107 (1), dju380, 2015
Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial
MM Mäenpää, K Nieminen, EI Tomás, M Laurila, TH Luukkaala, ...
American journal of obstetrics and gynecology 215 (5), 588. e1-588. e7, 2016
Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women
R Manchanda, S Patel, VS Gordeev, AC Antoniou, S Smith, A Lee, ...
JNCI: Journal of the National Cancer Institute 110 (7), 714-725, 2018
Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study
AN Rosenthal, LSM Fraser, S Philpott, R Manchanda, M Burnell, ...
Journal of Clinical Oncology 35 (13), 1411-1420, 2017
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule
AN Rosenthal, L Fraser, R Manchanda, P Badman, S Philpott, J Mozersky, ...
Journal of Clinical Oncology 31 (1), 49-57, 2013
Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status
R Manchanda, A Abdelraheim, M Johnson, AN Rosenthal, E Benjamin, ...
BJOG: An International Journal of Obstetrics & Gynaecology 118 (7), 814-824, 2011
A cost-effectiveness analysis of multigene testing for all patients with breast cancer
L Sun, A Brentnall, S Patel, DSM Buist, EJA Bowles, DGR Evans, ...
JAMA oncology 5 (12), 1718-1730, 2019
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual patient data
PA Cohen, A Powell, S Böhm, CB Gilks, CJR Stewart, TM Meniawy, ...
Gynecologic oncology 154 (2), 441-448, 2019
Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II
MHM Oonk, B Slomovitz, PJW Baldwin, HC Van Doorn, J Van der Velden, ...
Journal of Clinical Oncology 39 (32), 3623-3632, 2021
Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, ...
BJOG: An International Journal of Obstetrics & Gynaecology 119 (5), 527-536, 2012
Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome
A Kriplani, R Manchanda, N Agarwal, B Nayar
The Journal of the American Association of Gynecologic Laparoscopists 8 (4 …, 2001
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
R Manchanda, S Patel, AC Antoniou, E Levy-Lahad, C Turnbull, ...
American journal of obstetrics and gynecology 217 (5), 578. e1-578. e12, 2017
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
S Jervis, H Song, A Lee, E Dicks, P Harrington, C Baynes, R Manchanda, ...
Journal of Medical Genetics 52 (7), 465-475, 2015
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’for ovarian cancer prevention: a cost-effectiveness analysis
R Manchanda, R Legood, AC Antoniou, VS Gordeev, U Menon
Journal of medical genetics 53 (9), 591-599, 2016
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term outcomes
R Manchanda, M Burnell, F Gaba, R Desai, J Wardle, S Gessler, L Side, ...
BJOG: An International Journal of Obstetrics & Gynaecology 127 (3), 364-375, 2020
Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS)
R Manchanda, E Saridogan, A Abdelraheim, M Johnson, AN Rosenthal, ...
Archives of gynecology and obstetrics 286, 1555-1562, 2012
The system can't perform the operation now. Try again later.
Articles 1–20